Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sopris Capital is a private, active U.S.-based multi-strategy investment firm and family-office-backed capital provider rather than an operating drug-development company. The firm invests across venture capital, private equity, and real estate, with its venture strategy emphasizing healthcare, healthcare IT, and technology-enabled business services. In healthcare, Sopris Capital has backed companies involved in clinical trial technology, patient recruitment, real-world data, and other healthcare services and software workflows. It appears to invest long-term proprietary capital and positions itself as a patient, flexible partner to growth-stage businesses. For biotech analysts, Sopris Capital is best characterized as a healthcare-focused investor with exposure to life sciences tools and healthtech, not as a therapeutics developer with an internal R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sopris Capital.